Catalyst Wire Dossier Catalyst Wire Dossier

hypotonic treprostinil subcutaneous infusion

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for hypotonic treprostinil subcutaneous infusion, covering 2020-03-03 to 2020-03-03. Get the full timeline:

Most recent: Clinical Trial Update: Hypotonic Treprostinil Subcutaneous Infusion for Control of Treprostinil Related Site Pain [Phase 4]

See pricing